Dr Erica Andersen-Nissen Laboratory Director Cape Town

Dr Erica Andersen-Nissen Laboratory Director Cape Town

Dr Erica Andersen-Nissen Laboratory Director Cape Town leads the Cape Town HVTN Immunology Lab, where scientists evaluate immune responses to HIV and tuberculosis vaccines. The laboratory opened in October 2013 and has grown into a leading research hub. Its main goal is to support the HIV Vaccine Trials Network (HVTN) in developing safe and effective vaccines to prevent HIV infections worldwide.

The lab focuses on practical, hands-on research. Dr Erica Andersen-Nissen Laboratory Director Cape Town ensures all assessments are precise and timely. Researchers study how candidate vaccines stimulate the immune system and work closely with local investigators to uncover novel immune responses. These efforts contribute directly to improving global vaccination strategies.

Laboratory Research Focus

The Cape Town HVTN Immunology Lab specializes in:

• Assessing immune responses to candidate HIV and tuberculosis vaccines

• Conducting high-quality clinical laboratory research

• Collaborating with local and international researchers

• Training African scientists in cutting-edge laboratory techniques

The lab’s work is essential for advancing vaccine science. It provides accurate and reliable data to the HVTN headquarters in Seattle, WA, USA, at the Fred Hutch Cancer Center. By participating in these studies, the lab helps bridge the gap between clinical trials and practical vaccine development.

Training and Mentorship

She leads a strong training program for emerging African scientists. The lab provides mentorship in modern immunology techniques, ensuring researchers gain skills in:

• Sample processing and analysis

• Laboratory quality control and standards

• Data interpretation for clinical trials

• Identifying immune biomarkers

These training programs enhance local capacity and strengthen scientific expertise across the region.

Collaboration and Innovation

Collaboration is a core part of the lab’s mission. The team works with local universities, hospitals, and global research partners to explore new vaccine approaches. By sharing insights and findings, the lab contributes to a broader understanding of immune protection against HIV and tuberculosis.

Ongoing Projects

The lab’s current projects include:

• HIV Vaccine Trials Network (HVTN) studies

• Evaluating novel tuberculosis vaccines

• Immune response profiling for vaccine candidates

• Supporting regional and global clinical trial initiatives

Contact Information

For inquiries, collaborations, or training opportunities, She can be reached directly via email. The lab encourages scientists and healthcare professionals to engage with its ongoing research programs.

Dr Erica Andersen-Nissen Laboratory Director Cape Town ensures the Cape Town HVTN Immunology Lab maintains world-class standards in research, training, and innovation. The lab continues to play a critical role in improving public health and advancing the fight against HIV and tuberculosis in South Africa and beyond.